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Abstract: In diabetic patients, high blood glucose induces alterations in retinal function and can lead
to visual impairment due to diabetic retinopathy. In immortalized retinal pigment epithelial (RPE)
cultures, high glucose concentrations are shown to lead to impairment in epithelial barrier properties.
For the first time, the induced pluripotent stem-cell-derived retinal pigment epithelium (hiPSC-RPE)
cell lines derived from type 2 diabetics and healthy control patients were utilized to assess the effects
of glucose concentration on the cellular functionality. We show that both type 2 diabetic and healthy
control hiPSC-RPE lines differentiate and mature well, both in high and normal glucose concentrations,
express RPE specific genes, secrete pigment epithelium derived factor, and form a polarized cell
layer. Here, type 2 diabetic hiPSC-RPE cells had a decreased barrier function compared to controls.
Added insulin increased the epithelial cell layer tightness in normal glucose concentrations, and the
effect was more evident in type 2 diabetics than in healthy control hiPSC-RPE cells. In addition,
the preliminary functionality assessments showed that type 2 diabetic hiPSC-RPE cells had attenuated
autophagy detected via ubiquitin-binding protein p62/Sequestosome-1 (p62/SQSTM1) accumulation,
and lowered pro- matrix metalloproteinase 2 (proMMP2) as well as increased pro-MMP9 secretion.
These results suggest that the cellular ability to tolerate stress is possibly decreased in type 2 diabetic
RPE cells.
Keywords: retinal pigment epithelial cells; type 2 diabetes; diabetic retinopathy (DR);
induced pluripotent stem cells (hiPSC); barrier function; autophagy; matrix metalloproteinase
1. Introduction
Diabetic retinopathy (DR), the major complication in patients with diabetes, is a leading cause of
preventable vision loss in working-aged people in industrialized nations [1–3]. DR is estimated to
account for 15–17% of total blindness in Europe and USA [4]. Twenty years after the onset of diabetes,
almost all (90%) patients with type 1 diabetes and half (50%) of patients with type 2 diabetes have
some form of DR. One third of patients with type 2 diabetes have DR-type changes at the time of
diagnosis [1,4].
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DR can be divided into nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic
retinopathy (PDR). The NPDR is characterized by microaneurysms (i.e., dilation of capillaries,
(Figure 1a), hard and soft exudates (Figure 1a), vessel dilatations and tortuosity, haemorrhages
(Figure 1a), and intraretinal microvascular abnormalities (Figure 1b).
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Figure 1. (a) Fundus photograph of donor of UTA.08203.EURCCS cell line having severe diabetes 
retinopathy with a microaneurysm (black arrow), hemorrhage (white arrow), and soft exudate (green 
arrow). (b) A red free fundus photograph from the same patient with intraretinal microvascular 
abnormalities (IRMA) pointed with an arrow. 
NPDR can be classified according to mild (only microaneurysms), moderate (more than 
microaneurysms), and severe retinopathy (many complications in all retina sections) levels. The 
NPDR stages are primarily a consequent of increased hyperglycemic, oxidative stress, hypoxia, and 
inflammation conditions that may lead to the PDR, which is characterized by the growth of new, but 
fragile, retinal vessels [1]. The vascular leakage from these newly formed vessels can lead to swelling 
of the macula, and hence to the macular edema, which is the most common cause of blindness in 
diabetic patients [1,5]. Endothelial pathology in DR has been characterized in detail, but the effects in 
the outer retina, in retinal pigment epithelium (RPE), has drawn rather little attention [1–3,5–8].  
RPE cells are a polarized monolayer of cells that form a tight and selective diffusion barrier 
between the choroid and the neural retina [1–3]. It has been widely accepted that the increased 
glucose concentration escalates leakiness of the outer retina [1–3]. The hyperglycemic stimuli have 
been shown to decrease the barrier function in diabetic rodents [9] and decrease the tightness of the 
RPE cell layer in immortalized ARPE-19 cell cultures [10,11]. The hyperglycemic stimuli has also been 
shown to increase extracellular matrix protein, such as collagen and laminin [12,13], extracellular 
matrix organizing protein, such as matrix metalloproteinases (MMP) [14,15] production, and the 
expression of pigment epithelial growth factor (PEDF) [16,17].  
Pathogenesis of DR has been studied for decades by using rodents, dogs, pigs, and non-human 
primates [1], as well as retinal ex vivo cultures [18] and primary cells isolated from diabetic patients 
[15,16]. However, the limitation of these diabetic patient cell/tissue culture approaches is their 
inherent heterogeneity [1]. Therefore, a feasible option to achieve a disease-specific cell type is to use 
donor specific human induced pluripotent stem cells (hiPSCs) [1,19]. 
Autophagy is a host defense response to many environmental stresses observed in retinal 
diseases such as glycative stress, nutrient deprivation, hypoxia, or oxidative stress [20]. In autophagy, 
the autophagosome seals the content destined to degradation and fuses with a lysosome to degrade 
the cargo. In this process, the p62/SQSTM1 (sequestosome 1) protein, which also has a role in anti-
oxidant cytoprotection via the NRF-2/ARE (nuclear erythroid 2-related factor 2/antioxidant response 
element) pathway, sort and bind the cargo for autophagic degradation and binds with LC3 
(microtubule-associated protein 1A/1B-light chain) to form autophagosome and seal the cargo [21]. 
Both of these proteins are degraded along with the cargo and are therefore used for monitoring 
autophagy markers [22]. Similarly, increased oxidative stress, disturbed proteostasis, and 
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NPDR can be classified according to mild (only microaneurysms), moderate (more than
microaneurysms), and severe retinopathy (many complications in all retina sections) levels.
The NPDR stages are primarily a consequent of increased hyperglycemic, oxidative stress, hypoxia,
and inflammation conditions that may lead to the PDR, which is characterized by the growth of new,
but fragile, retinal vessels [1]. The vascular leakage from these newly formed vessels can lead to
swelling of the macula, and hence to the macular edema, which is the most common cause of blindness
in diabetic patients [1,5]. Endothelial pathology in DR has been characterized in detail, but the effects
in the outer retina, in retinal pigment epithelium (RPE), has drawn rather little attention [1–3,5–8].
RPE cells are a polarized monolayer of cells that form a tight and selective diffusion barrier
between the choroid and the neural retina [1–3]. It has been widely accepted that the increased glucose
concentration escalates leakiness of the outer retina [1–3]. The hyperglycemic stimuli have been shown
to decrease the barrier function in diabetic rodents [9] and decrease the tightness of the RPE cell layer in
immortalized ARPE-19 cell cultures [10,11]. The hyperglycemic stimuli has also been shown to increase
extracellular matrix protein, such as collagen and laminin [12,13], extracellular matrix organizing
protein, such as matrix metalloproteinases (MMP) [14,15] production, and the expression of pigment
epithelial growth factor (PEDF) [16,17].
Pathogenesis of DR has been studied for decades by using rodents, dogs, pigs, and non-human
primates [1], as well as retinal ex vivo cultures [18] and primary cells isolated from diabetic
patients [15,16]. However, the limitation of these diabetic patient cell/tissue culture approaches
is their inherent heterogeneity [1]. Therefore, a feasible option to achieve a disease-specific cell type is
to use donor specific human induced pluripotent stem cells (hiPSCs) [1,19].
Autophagy is a host defense response to many environmental stresses observed in retinal
diseases such as glycative stress, nutrient deprivation, hypoxia, or oxidative stress [20]. In autophagy,
the autophagosome seals the content destined to degradation and fuses with a lysosome to degrade
the cargo. In this process, the p62/SQSTM1 (sequestosome 1) protein, which also has a role in
anti-oxidant cytoprotection via the NRF-2/ARE (nuclear erythroid 2-related factor 2/antioxidant
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response element) pathway, sort and bind the cargo for autophagic degradation and binds with LC3
(microtubule-associated protein 1A/1B-light chain) to form autophagosome and seal the cargo [21].
Both of these proteins are degraded along with the cargo and are therefore used for monitoring
autophagy markers [22]. Similarly, increased oxidative stress, disturbed proteostasis, and accumulated
toxic compounds trigger the progression from para-inflammation to chronic inflammation [20,23].
In previous studies, diabetic patient-derived hiPSCs have already been differentiated into
cardiomyocytes [24] and insulin-producing cells [25], but according to our knowledge, there is
no publications of differentiation of hiPSCs into RPE cells. In this study, we assessed the development
of the barrier function of type 2 diabetic patient-derived hiPSC-RPEs assessed under different glucose
concentrations in the presence or absence of added insulin. In addition, the functionality was
preliminarily investigated under oxidative stress, and autophagic and cytokine stimuli.
2. Results
2.1. Pluripotency Assessment
Here, the hiPSC lines, three (UTA.08002.DMs, UTA.08203.DMs, and UTA.10802.EURCCs) from
type 2 diabetics and two (UTA.10212.EURCCs, and UTA.10902.EURCCs) from controls used in this
study were characterized in detail for their pluripotency. In all five hiPSC lines the virally transferred
exogenous pluripotency genes (OCT4, c-MYC, SOX2, and KLF) were silenced (Figure 2a) and they
all expressed the pluripotency markers of OCT4, REX1, SOX2, NANOG, and c-MYC at the gene level
(Figure 2b). The pluripotency of iPSC lines was verified in vitro using embryoid body(EB) formation,
from which we showed using PCR that EBs were expressing at least one marker from each of the three
germ layers (endoderm, mesoderm, and ectoderm) (Figure 2c). Furthermore, the results from indirect
immunofluorescence staining confirmed the expression of NANOG, OCT4, SOX2, SSEA4, TRA1-60,
and TRA1-80 at the protein level (Figure 2d). During the time of the experiment, the karyotypes of all
five iPSC lines were normal (Figure 2e).
2.2. Maturation Status of Cells Verified with Gene Expression and Morphology
The maturation of PREs was characterized using visual detection of pigmentation (Figure 3a–d).
Although there were slight differences in the intensity of pigmentation, all characterized cell lines
had a cobblestone morphology and pigmentation. In the representative immunofluorescent staining,
all analyzed cell lines were positive for tight junction localizing ZO-1 (Figure 3e–h). The maturation
was further assessed with transmission electron microscopy (TEM), in which all the characterized cell
lines exhibited pigment granules as well as a thick and even brush border (Figure 3i–l).
The differentiation and maturation status of hiPSC-RPEs derived from type 2 diabetics
(UTA.08002.DMs, UTA.08203.DMs, and UTA.10802.EURCCs), and healthy control (UTA.10212.EURCCs
and UTA.10902.EURCCs) patient hiPSC-RPEs was assessed using RT-PCR after five weeks of culture
on polyethylene terephthalate (PET) inserts in normal (NG) or high glucose (HG) (Figure 3m).
The pluripotency gene Oct3/4, a marker of undifferentiated hiPSCs, was quiescent, and PAX6, a marker
of neuroectodermal and eye-specific lineage, was expressed in low levels. Bestrophin (BEST1),
a RPE-specific gene, was expressed in all analyzed cell lines. The RPE65, another RPE-specific gene,
was expressed in all cell lines. The tyrosinase gene, which is essential for melanin synthesis, was
expressed in high levels in type 2 diabetic hiPSC-RPE line UTA.08002.DMs, and in healthy control
hiPSC-RPE lines UTA.10212.EURCCs and UTA.10902.EURCCs, and low levels in type 2 diabetic hiPSC
lines UTA.08203.DMs and UTA.10802.EURCCs (Figure 3m).
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MYC. (c) All five hiPSC lines formed embryoid bodies (EBs) expressing at least one marker from each 
of the germ layers: endoderm (AFP, SOX17), mesoderm (KDR, α-cardiac actin α AC), and ectoderm 
(SOX1, POX6). (d) The expression of pluripotency markers in all iPSC lines were confirmed at the 
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Figure 2. Characterization of the human induced pluripotent stem cell (hiPSC) line gene and protein
expression and analyses of their karyotype. (a) The virally transferred Sendai exogenes OCT4, c-MYC,
SOX2, and KLF4 were silenced in all the iPSC lines. The RNA that was extracted one week after the viral
transduction was taken as a positive control. GAPDH was used as a housekeeping ge . (b) All the five hiPSC
lines expressed endogenous pluripotency genes OCT4, REX1, SOX2, NANOG, and c-MYC. (c) All five hiPSC
lines formed embryoid bodies (EBs) expressing at least one marker from each of the germ layers: endoderm
(AFP, SOX17), mesoderm (KDR, α-cardiac actin α AC), and ectoderm (SOX1, POX6). (d) The expression of
pluripotency markers in all iPSC lines were confirmed at the protein level using indirect immunofluorescence
staining. The red color indicates the specific signal for NANOG, OCT4, SOX2, SSEA4, TRA1-60, and TRA1-81,
and the blue color indicates the nuclei stained using DAPI (4′,6-diamidino-2-phenylidole). The scale bar
represents 200µm. (e) Karyotype analyses of five hiPSC lines. Red and blue dots indicate chromosomal signal
ratios of sample DNA against male (blue) or female (red) reference normal karyotype DNA, as detected
using a KaryoLiteTM BoBs™ assay. Signal from normal chromosomes should lie inside the reference
area around value 1, while with an abnormal karyotype, signals lie outside the reference area. Cell lines
UTA.08002.DMs, UTA.08203.DMs, and UTA.10802.EURCCs showed a normal male karyotype, and cell lines
UTA.10212.EURCCs, and UTA.10902.EURCCs showed a normal female karyotype.
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Figure 3. Characterization of RPE specific features. (a–d) The phase contrast micrographs taken after 
the five weeks of cultivation showed a substantial amount of pigmentation in type 2 diabetic and 
healthy control cell lines (a) type 2 diabetic, UTA.08002.DMs; (b) type 2 diabetic, UTA.08203.DMs; (c) 
fi
fi
l tr l cell lines (a) type 2 diabetic, UTA. 8002.DMs; (b) type 2 diabetic, UTA. 8203.DMs;
(c) type 2 diabetic, UTA.10802.EURCCS; and (d) healthy control, UTA.10902.EURCCs. The scale
bar represents 20 µm. (e–h) Immunofluorescent staining of tight junction ZO-1 localized to the
cell edges. (e) type 2 diabetic, UTA.08002.DMs; (f) type 2 diabetic, UTA.08203.DMs; (g) type 2
diabetic, UTA.10802.EURCCS; and (h) healthy control, UTA.10902.EURCCs. The scale bar represents
20 µm. Transmission electron micrographs reveal that hiPSC-RPEs were growing in a monolayer, have
melanin granules and a thick brush border. (i) type 2 diabetic, UTA.08002.DMs; (j) type 2 diabetic,
UTA.08203.DMs; (k) type 2 diabetic, UTA.10802.EURCCS; and (l) healthy control, UTA.10902.EURCCs.
The scale bar represents 2 µm. (m) The RPE cells differentiated from type 2 diabetic (UTA.08002.DMs,
UTA.08203.DMs, UTA.10802.EURCCs) and healthy control (UTA.10212.EURCCs, UTA.10902.EURCCs)
cells during five weeks of time in normal (NG) or high (HG) glucose concentration, as studied in
RT-PCR. The hiPSCs expressed the housekeeping gene GAPDH, and eye-specific lineage marker PAX6,
as well as RPE-specific marker Bestrophin (BEST), and low amounts of tyrosinase, but no pluripotency
marker OCT3/4. The negative controls (marked with H2O) are shown on the right-hand side.
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2.3. Barrier Properties in hiPSC-RPE Cells
When RPE cells mature, they form a tight, uniform, and polarized cellular monolayer. We followed
the maturation of hiPSC-RPE cells derived from diabetic or healthy control individuals grown in
different high or normal glucose concentrations in the presence or absence of added insulin over
five weeks. The maturation of epithelial cell layer was evaluated by assessing the trans-epithelial
electrical resistance (TEER). Both the type 2 diabetic and healthy control hiPCS-RPEs matured and
the TEER increased during the follow-up period (Figure 4a,b). TEER in HG+ in type 2 diabetic cells
was 313 Ω·cm2 and in healthy control cells in HG+ was 208 Ω·cm2. Statistical analysis verified that
the difference was statistically significant (p = 0.03). There were statistically significant changes in
TEER in NGM+, NG+, and NG− between the type 2 diabetic and healthy control cells, as illustrated in
Figure 4c (NGM− p = 0.011, NG+ p = 0.017, and NG− p = 0.017).
Then, we compared the TEER within cell groups when cultured in different glucose concentrations.
Both type 2 diabetic and healthy control hiPSC-RPEs grown in HG+ had higher TEER than those
grown in NGM−, and this difference was statistically significant (p = 0.01 and p = 0.016, respectively).
In addition, there were statistically significant differences between conditions NGM− and NGM+, in
type 2 diabetic (p = 0.006) and in healthy control (p = 0.041) cells.
The tightness of the epithelial cell layer was evaluated at the end of the cultivation period by
assessing the cumulative permeability percentage of a small-molecular-weight fluorescent marker (FD4)
through the hiPSC-RPE epithelial cell layer in an Ussing chamber system (Figure 5a–c). During the five
weeks culture period, all hiPSC-RPE cultures had formed a tightly sealed cell layer as the cumulative
permeability percentage of FD4 was close to 0 in both type 2 diabetic and healthy control hiPSC-RPEs
(Figure 5a,b). When the endpoint at 240 min was plotted, it is seen that the type 2 diabetic hiPSC-RPE
cultures were more permeable than healthy control hiPSC-RPEs (Figure 5c). The most statistically
significant differences (p = 0.004) were found when the NGM+ condition was compared between type
2 diabetic (cumulative permeability % = −0.012) and healthy control (cumulative permeability % =
−0.057) hiPSC-RPEs (Figure 5c).
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(FD4) through the hiPSC-RPE epithelial cell layer in an Ussing chamber system (Figure 5a–c). During 
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Figure 4. Development of barrier function in dia d healthy control hiPSC-RPEs. Cells were
cultured for 5 weeks in different glucose and ins li centrations (see treatments and abbreviations
below). The development of trans-epithelial electrical resistance (TEER) during the five-weeks culture:
(a) represents three type 2 diabetic cell lines (UTA.08002.DMs, UTA.08203.DMs, UTA.10802.EURCCs)
(n = 3–4 biological, and 2 technical replicates); (b) represents one healthy control cell line
(UTA.10902.EURCCs) (n = 3 biological, and 2 technical replicates). (c) The TEER after 35 days
of culture. Data are presented as mean ± SD. Statistical significance * p < 0.05, ** p < 0.01. HG represents
high glucose (25 mM); NG represents normal glucose (5 mM); NGM represents normal glucose (5 mM)
balanced with mannitol (19.5 mM). DM− is the control culture medium, which is ordinarily used for
hiPSC maturation.
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2.4. Effects of Glucose Concentration on the Secretion of the RPE-Specific Growth Factor (PEDF) Secretion 
Mature RPE cells normally synthetize and apically secrete PEDF growth factor. As PEDF is a 
marker of RPE cell wellbeing, and using this, we wanted to see whether different concentrations of 
Figure 5. Cumulative permeability in diabetic and healthy control hiPSC-RPEs. After the 5-week
culture, the hiPSC-RPEs were subjected to permeability analysis (a–c). The cumulative transport
percentage of 4 kDa Fitc dextran (FD4) from the apical to basal side of hiPSC-RPE in an Ussing chamber
system over 240 min in (a) type 2 diabetic, and (b) healthy control cells. The endpoint measurement
of cumulative transport percentage at the 240 min time point is shown in separate graphs resented
in (c). D ta are presented as mean ± SD. Statistical significance p < 0.01 marked as **. HG represents
high luco e (25 mM); NG represents normal glucose (5 mM); NGM represents normal glucose (5 mM)
balanced with man itol (19.5 mM). All conditions had +/− added insulin. DM− is the control culture
medium, which is ordinarily used for hiPSC maturation.
2.4. Effects of Glucose Concentration on the Secretion of the RPE-Specific Growth Factor (PEDF) Secretion
Mature RPE cells normally synthetize and apically secrete PEDF growth factor. As PEDF is a
marker of RPE cell wellbeing, and using this, we wanted to see whether different concentrations of
glucose and/or insulin have an effect on PEDF secretion. During a 24 h collection time, all studied
hiPSC-RPEs secreted a substantial amount (>500 ng/mL) of PEDF (Figure 6) from their growth area
(0.3 cm2). The type 2 diabetic hiPSC-RPE lines secreted on average 495–610 ng/mL PEDF, which was
less than healthy control hESC-RPEs (627–670 ng/mL). However, none of these differences was
statistically significant as the highest significance in statistical analyses was p = 0.06 between type
2 diabetic and healthy control hiPSC-RPEs in NGM− (Figure 6). The type 2 diabetic and healthy
control hiPSC-RPE cells secreted higher amounts of PEDF on the apical side than on the basal side
(Supplemental Figure S1a,b).
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Figure 6. The effects of glucose and insulin concentration and extracellular stress on pigment
epithelial growth factor (PEDF) secretion. The amount of PEDF was assessed using enzyme-linked
immunosorbent assay (ELISA) from medium samples after a 24 h collection of apical and basal side
(1 + 1). Medium was from hiPSC-RPEs derived from type 2 diabetic (UTA.08002.DMs, UTA.08203.DMs,
and UTA.10802.EURCCs) and healthy control (UTA.10902.EURCCs) patients (1–3 biological replicates,
1 technical replicate).
2.5. Effects of Glucose Concertation’s on Glucokinase Gene Expression
Changes in the glucokinase (GCK) activity are involved in the glucose uptake, and its
expression is affected by the insulin concentration [26]. As we did not detect any clear glucose
concentration-dependent alterations in PEDF secretion, we ran a preliminary analysis (one biological
replicate and three technical replicates) to see how glucose and insulin concentration effected GCK
gene expression. The result showed that, except in the NG- condition, the expression of GCK was
higher in type 2 diabetic cells than the healthy control in various conditions (Figure 7).
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Figure 7. The preliminary assessment of glucokinase (GCK) gene expression in different glucose and
insulin concentrations. Expression of GCK in type 2 diabetic (UTA.08002.DMs) or healthy control
(UTA.10902.EURCCs) patient-derived hiPSC-RPEs (three technical replicates, one biological replicate)
was studied when cultured in different l cose and insulin concentrations (see treatments and
abbreviati s below). Treatments a d their abbreviations: High glucose (HG, 25mM), normal glucose
5 mM balanced with mannitol 19.5 mM (NGM), or normal glucose (NG, 5 mM) in the presence or
absence (+/−) of added insulin. Each bar represents the medium of three technical replicates.
2.6. Effects of Glucose on Autophagy
The pr liminary unctionality assessment (with one biological replicat ) of autophagic machinery
in the hiPSC-RPE lines was done by evaluating autophagy marker protein LC3-II and p62/SQSTM1
expression from the Western blots of whole cell protein extracts (Figure 8a–c). Compared to control,
autophagy stimuli 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) increased the relative
LC3-II level in both type 2 diabetic and healthy control hiPSC-RPEs in almost all glucose and insulin
concentrations (Figure 8d–f) in healthy hiPSC-RPEs. Starvation, which is also known to activate
autophagy, clearly decreased the relative amounts of LC3-II in type 2 diabetic and healthy control
hiPSC-RPE and in all glucose and insulin concentrations (Figure 8d–f). We did not detect any difference
in the LC3-II expression between diabetic or healthy control hiPSC-RPEs. Interestingly, in type 2
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diabetic hiPSC-RPEs, there was clearly higher p62/SQSTM1 accumulation levels than in healthy control
hiPSC-RPEs (Figure 8g–h). Additionally, the presence of insulin seemed to negatively affect the
accumulation of p62/SQSTM in the cells, and particularly in type 2 diabetic hiPSC-RPEs.
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Figure 8. Activation f autophagy was analyz hiPSC-RPE cells derived from type 2 d abetic
(UTA.08203.DMs) or healthy contr l (UTA.10902.EURCCs) patients cultured in high glucose ( , 25 mM,
(a,d)), normal glucose (5 mM) balanced with mannitol (19.5 mM) (NGM, b,e,g), or normal glucose (NG,
5 mM, (c,f,h)) for five weeks. Thereafter, cultures were subjected to 5-aminoimidazole-4-carboxyamide
ribonucleoside (AICAR, 2 mM), starvation (no serum), or resveratrol (20 mM) for 24 h, and whole
proteins were extracted and analyzed using Western blots labelled with LC3, p62/SQSTM1, and α-tubulin.
The Western blots are represented in (a–c). The line on the left denotes the size of the blot. The α-tubulin
band was used as a loading control. The values are correlated to the untreated sample, which is marked as
1. AICAR increased the relative LC3-II level in both diabetic and healthy control hiPSC-RPEs and in all
glucos and insulin concentr tions (d–f). Starvation resulted in decreased relative amounts of LC3-II in
both diabeti and healthy contr l hiPSC-RPE in all glucose and insulin concentrations (d–f). In diabetic
hiPSC-RPEs, the lev ls of relative p62/SQSTM1 were clearly higher than for healthy control cells (g–h).
2.7. Effects of Glucose and Insulin Concentration and Stress Inducers on MMP Secretion
We carried out a preliminary functionality assessment, with one biological replicate, mimicking
diabetic retinopathy conditions with the oxidative stress and cytokine stimuli. Thereafter, the activity
of pro matrix metalloproteinases was evaluated. Both type 2 diabetic and healthy control hiPSC-RPEs
expressed a band of 58.3 ± 5.3 kDa, corresponding to MMP2, and a band with molecular weight
of 121.7 ± 8.0 kDa, corresponding to a high-molecular weight band in zymography (Figure 9a).
Our analysis showed that the amount of pro-MMP2 was higher in healthy control hiPSC-RPEs than
in type 2 diabetic hiPSC-RPEs (Figure 9b), while the pro-MMP9 was slightly more expressed in the
diabetic than healthy control cells (Figure 9c). Tumor necrosis factor α (TNFα) treatment resulted in
an increased pro-MMP2 expression in both type 2 diabetic and healthy hiPSC-RPEs; on the contrary,
the oxidative stress with H2O2 resulted in decreased pro-MMP2 expression in both cell types (Figure 9d).
The pro-MMP9 expression was increased in both diabetic and healthy hiPSC-RPEs by TNFα, and the
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highest increase was detected in HG+ in both cell types (Figure 9e). The H2O2 caused a modest
decrease in pro-MMP9 expression in both cell types (Figure 9e).Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 12 of 24 
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The type 2 diabetic (UTA.08 03.DMs) and healthy control (UTA.10212.EURCCs and UTA.10902.EURCCs)
hiPSC-RPEs were cultured in different glucose and insulin concentrations (see treatments and abbreviations
below) in the presence or absence (+/−) of added insulin (a–d), and in the presence or absence of TNFα (48 h)
or H2O2 (1 h + 23 h). (a) represents the exemplary zymographies with diabetic (left) and healthy (right)
control samples. The densitometric evaluation of zymograms are shown in panels (b–d). The densitometric
analysis of pro-MMP2 (b) and pro-MMP9 were n rmalized to a 100 kDa marker (c). The densitometric
evaluation of p o-MMP2 after 0 ng/mL TNFα (48h) or 300 mM H2O2 (1 h + 23 h) in diabetic o healthy
control hiPSC-RPE, and the values are correlated to the untreated sample, which is marked as 1 (d).
The densitometric evaluation of pro-High molecular weight matrix metalloproteinase (HMW MMP) after
10 ng/mL TNFα or 300 mM H2O2 (1 h + 23 h) in diabetic or healthy control hiPSC-RPEs, where the values
are correlated to the untreated sample, which is marked as 1 (e). Treatments and their abbreviations: high
glucose (HG, 25 mM), normal glucose 5 mM balanced with mannitol 19.5 mM (NGM), or normal glucose
(NG, 5 mM) in the presence or absence (+/−) of added insulin.
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2.8. Effects of Glucose Concentration and Cytokine Stimulation on COL4A1, FN, and LAMA1 Gene Expression
We carried out preliminary functionality assessments (with one biological replicate and three
technical replicates) mimicking diabetic retinopathy conditions, with the oxidative stress and cytokine
stimuli. Thereafter, we analyzed the effects on the extracellular matrix protein expression known to
be affected in diabetic retinopathy. Quantitative RT-PCR showed that the TNF-α treatment increased
COL4A1 gene expression by at least 1.5-fold compared to unstimulated cells in all other glucose and
insulin concentrations except NG+ in type 2 diabetic hiPSC-RPEs (Figure 10a). In healthy control
hiPSC-RPEs, TNF-α treatment resulted in a 2.5-fold increase in the COL4A1 gene expression in NGM−,
and 1.6-fold increase in NGM+, but a decrease in NG− grown cultures (Figure 10b). The expression of
FN1 was increased in diabetic hiPSC-RPEs after TNF-α treatment, and the highest induction was in
NGM−, which had 4.8-fold increase, and found to be statistically significant (p = 0.05) (Figure 10c).
The trend after the TNF-α treatment was the same in healthy control hiPSC-RPEs where the NGM− had
the highest FN1 induction (four-fold increase, p = 0.05) (Figure 10d). The LAMA1 gene expression was
modestly increased in type 2 diabetic hiPSC-RPEs after the TNF-α treatment (Figure 10e), whereas in
healthy control hiPSC-RPEs, it resulted in to up to a five-fold increase (NGM− condition) gene
expression, which was statistically significant (p = 0.05) (Figure 10f).
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Figure 10. Effects of different glucose concentrations, and cytokine and oxidative stress on Collagen IV
(COL4A1), fibronectin (FN1), and laminin A1 (LAMA1) gene expression in hiPSC-RPEs derived from
type 2 diabetic (UTA.08203.DMs: (a,c,e)) or healthy control (UTA.10902.EURCCs: (b,d,f)) patients.
The hiPSC-RPEs were cultured in different glucose and insulin concentrations (see treatments and
abbreviations below) in the presence or absence (+/−) of added insulin, and in the presence or absence
of TNFα (48 h treatment). Overall, the 48 h TNFα treatment induced COLA1, FN1, and LAMA1
expression. The housekeeping gene GAPDH was used as a loading control and calibrator. Data
are expressed as mean ± SD of three replicates. The statistical significance is presented against the
control: * p ≤ 0.05. Treatments and their abb eviations: high glucose (HG, 25 mM), n mal glucose
5 mM balance w th mannitol 19.5 mM (NGM), or normal glucose (NG, 5 mM) in the presence or
absence (+/−) of added insulin.
3. Discussion
High glucose concentrations in diabetic patients alter the functionality in retinal cells [1]. In the
inner retina, the high glucose concentrations are shown to increase the permeability and decrease
the viability of endothelial cells [1,27]. Although the effects of a high glucose concentration in the
inner retina have been carefully assessed, there has been only few studies on its effects in the outer
retina [1–3,6–8,10]. According to our knowledge, there are no previous publications in which the
maturation of hiPSC-RPEs derived from type 2 diabetics and healthy controls have been assessed in
high or normal glucose concentration in the presence or absence of added insulin. When RPE specific
gene expression or PEDF secretion was assessed, both type 2 diabetic and healthy control hiPSC-RPEs
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matured well at all glucose concentrations in the presence or absence of added insulin. In previous
studies in which human immortalized RPE cells have been cultured in different glucose concentrations,
the glucose stimuli extended from three to 18 days [10,28–31]. Here the hiPSC-RPEs were cultivated in
different glucose concentrations for up to five weeks, during which, the cells might have been adapted
to different glucose concentrations.
The tight junction integrity, also called the barrier function, is essential for the retinal
functionality [3]. The barrier function of the epithelial cell layer can be analyzed by assessing
TEER, which is a measure of electrical resistance, or cumulative permeability percentage, which is the
flux of small molecular weight molecules. In previous studies, the retinas of diabetic rodents have been
more permeable to solutes than healthy controls [9]. The high glucose concentration has also been
shown to affect ARPE-19 cells, either by lowering TEER and increasing permeability of fluorescently
labelled dextran [28,29], or by increasing the TEER and reducing the permeability [10]. In our study,
the TEER increased over the five-week culture in all glucose concentrations in both type 2 diabetic and
healthy control hiPSC-RPE cultures. After five weeks, the cumulative permeability percentage was
close to zero, both in type 2 diabetic and healthy control hiPSC-RPEs, meaning that cultures, irrespective
of the glucose or insulin concentrations, were highly polarized and non-permeable. Still, the type 2
diabetic hiPSC-RPEs in all assessed conditions were slightly more permeable than healthy control.
Quite unexpectedly, after five weeks of culture, the epithelial layer was tighter in high glucose
(HG+) concentration than in normal glucose (NGM−) concentration. This phenomenon was evident
and statistically significant in both type 2 diabetic and healthy control hiPSC-RPEs (p = 0.003 or
p = 0.009). It should be noted that when HG+ were compared to the NG−, the statistical significance
dropped in both type 2 diabetic and healthy control hiPSC-RPEs from p ≈ 0.006 to p ≈ 0.4. This suggests
that not only glucose concentration, but also osmolality, may have had an impact on hiPSC-RPE
maturation. In addition, our data suggests that insulin concentration also had an effect on junctional
integrity, as the NGM+ and NGM− had statistically significant differences, both in type 2 diabetic and
healthy control hiPSC-RPE cultures.
PEDF secretion is a sign of a functional RPE [32]. The increase in PEDF secretion occurs
concomitantly with the maturation of hiPSC-RPE cells [33]. Previously, it has been shown that
high glucose concentration slightly increases the PEDF secretion in diabetic mice RPE [17] and in
immortalized human RPE cells (D407) [16]. In our study, type 2 diabetic hiPSC-RPEs and healthy
control hiPSC-RPEs secreted substantial amounts of PEDF (over 500 ng/mL), which can be taken as an
indication of good maturation status. The diabetic hiPSC-RPEs secreted slightly lower amounts of PEDF
than healthy control hiPSC-RPEs, but this difference was not statistically significant. We did not detect
any decrease in the PEDF secretion of hiPSC-RPEs after cultivation in high glucose concentrations.
Autophagy induction is an adaptive cellular response against cellular stress [34]. Previously,
the autophagy was shown to be altered in immortalized RPE cells in a high glucose concentration [35,36].
Interestingly, in this study, with one biological replicate, we could not observe differences in autophagy
in different glucose concentrations or between control and diabetic hiPSC-RPEs when LC3-II was
used as a biomarker. However, a clear accumulation of p62/SQSTM1 was detected in diabetic
hiPSC-RPEs compared to healthy control hiPSC-RPEs. In our hiPSC-RPEs, protein aggregates or
damaged cell organelles were not detectable and the formation pattern of autophagosomes (LC3-II)
was similar, which suggests another mechanism behind the elevated p62/SQSTM1 levels. In addition
to autophagy regulation, the p62/SQSTM1 interacts with the antioxidative NRF-2/ARE pathway by
disrupting the NRF-2-Keap1 complex [22,37]. This leads to nuclear localization of NRF-2 and induction
of antioxidant response element-driven gene transcription, including p62/SQSTM1, and creating a
positive feedback loop [21,37,38]. The upregulated p62/SQSTM1 levels in diabetic normal glucose
hiPSC-RPEs might be due to an evoked energy depletion, together with induced antioxidant production
via the NRF-2/ARE pathway.
The MMPs have long been thought to have a role in DR pathology [39], as increased MMP2 and
MMP9 levels have been detected from the vitreous of DR patients [14] and also in the immortalized
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human RPE cells’ (ARPE-19) activity of gelatinase (MMP2 and MMP9), and expression of gelatinase
(MMP2) [15] was shown to be increased after treatment with a high glucose concentration. In our pilot
study in which we had one biological replicate, the type 2 diabetic hiPSC-RPEs expressed a lower
amount of pro-MMP2, but a higher amount of pro-MMP9 compared to the healthy control hiPSC-RPEs
in all studied glucose concentrations. This result suggests that for type 2 diabetic hiPSC-RPEs,
the turnover of the extracellular matrix can be altered compared to a healthy control.
TNFα is a multifunctional cytokine that has been implicated to have a role in pathologic events in
early DR development [40]. Increased amounts of TNFα has been found in the vitreous of diabetic
patients [41] and in diabetic rat retinas [42]. When the diabetic environment was simulated with the
TNFα stimulation, we saw in the pilot assay with one biological replicate the increase in pro-MMP2 and
pro-MMP9 expression in both diabetic and healthy control hiPSC-RPEs. The similar kind of induction
in both type 2 diabetic and healthy control hiPSC-RPEs can be taken as an indication of the normal
responsiveness of cell lines.
The alterations in the expression of extracellular matrix components after the application of high
glucose have been described previously in the literature. For example, in immortalized ARPE-19
cells, the high glucose induced the increased expression of FN, COL4, and LAM [12,13], but in RPE
cells extracted from diabetic mice, there was no difference in the expression of FN or COL4 under a
high glucose condition [17]. In our study, in the pilot assay with one biological replicate and three
technical replicates, we found no major differences between the type 2 diabetic and healthy control
hiPSC-RPEs in COL4A1, FN, and LAMA1 extracellular matrix protein expression under the different
glucose concentrations. When we simulated the diabetic environment by adding TNFα to the cultures,
which resulted in a statistically significant increase in FN gene expression in NGM− cultures in both
diabetic and healthy control hiPSC-RPEs. This preliminary functionality assessment result carried out
with one type 2 diabetic and one healthy control hiPSC-RPE line, which can be taken as an indication
of normal responsiveness of these cells to cytokine stimuli.
4. Materials and Methods
4.1. Human Induced Pluripotent Stem Cell Reprogramming
Five hiPSC lines were used in this study, three cell lines (UTA.08203.DMs UTA.08002.DMs,
and UTA.10802.EURCCs) derived from type 2 diabetic patients and two lines (UTA.10212.EURCCs,
UTA.10902.EURCCs) derived from control individuals. All the diabetic patients had nephropathy
and neuropathy and universal atherosclerosis except one type 2 diabetic (UTA.10802.EURCCs).
Diabetic retinopathy was diagnosed in two type 2 diabetic (UTA.08002.DMs, UTA.08203.DMs) patients.
The fundus micrographs were from a type 2 diabetic (donor of UTA.08203.DMS), (see Figure 1).
The hIPSC lines were derived from skin biopsy extracted fibroblasts and the pluripotency
was induced by a Sendai-virus reprogramming kit (OCT4, SOX2, KLF4, C-MYC; CytoTuneTM;
Life Technologies) as described elsewhere [43,44].
4.2. Human Induced Pluripotent Stem Cell Culture
The hiPSC lines were cultured on mouse embryonic fibroblasts (MEFs, Applied StemCell Inc.,
Cat. No. ASF-1225) and maintained at +37 ◦C in 5% CO2 and were passaged on a weekly basis.
Cells were cultured with Knock-Out Dulbecco’s Modified Eagle Medium (KO-DMEM, Gibco®)
complemented with 20% Knock-Out Serum Replacement (Ko-SR, Gibco®), 2 mM Glutamax (Gibco®),
0.1 mM 2-mercaptoethanol (2-ME, Gibco®), 1% nonessential amino acids (NEAA, Lonza Group Ltd,
Basel, Switzerland) and 50 U/mL penicillin/streptomycin (Lonza Group Ltd., Basel, Switzerland).
Medium was supplemented with 4 ng/mL basic fibroblast growth factor (bFGF, R & D Systems Inc.,
Minneapolis, MN, USA). Cell lines were regularly checked for mycoplasma contamination.
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4.3. Human Induced Pluripotent Stem Cell Characterization
All the hiPSC lines were characterized in detail as we described before [45]. Briefly, the absence of
imported exogenes (OCT4, SOX2, KLF4, and c-MYC) and the expression of endogenous pluripotency
genes (OCT3/4, NANOG, SOX2, REX1, and c-MYC) was evaluated using PCR. The protein expression of
pluripotency markers OCT-3/4, Nanog, SSEA-4, SOX2, TRA 1-60, and TRA 1-81, was confirmed using
indirect immunofluorescence staining. In addition, the pluripotency of the hiPSCs was verified in vitro
via the formation of embryoid bodies (EBs). Then, the expression of marker genes characteristic of the
endoderm (SOX17 or AFP), mesoderm (KDR or ACTC1), or ectoderm (SOX1, PAX6, Nestin, or Musashi)
were studied from the extracted RNAs of the EBs and GAPDH was used as an endogenous control.
The list of primer sequences for pluripotency genes, marker genes of the three germ layers, and the list
of primary and secondary antibodies has been published before [46]. Normal karyotype of the hiPSC
lines was evaluated in the Finnish Microarray and Sequencing Centre by performing genome-wide
screening for gross chromosomal abnormalities with KaryoLite BoBs (Perkin Elmer, 4501–0010) as
described elsewhere [47].
4.4. Differentiation of Human Induced Pluripotent Stem Cells to Retinal Pigment Epithelial Cells
The differentiation towards RPE started by dissociating the undifferentiated cells cultured on top
of mitotically inactivated mitomycin (10 mg/mL, Sigma-Aldrich, St. Louis, MO, USA) treated human
foreskin fibroblasts feeder cell (CRL-2429TM, ATCC, Manassas, VA, USA) hiPSC colonies that were
enzymatically with TrypLE™ Select Enzyme (Gibco®, Thermo Fisher Scientific). These were transferred
to Corning® Costar® Ultra-Low attachment plates, and grown in Knock-Out™ Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 20% Knock-Out™ SR (KO-SR), 1% MEM non-essential
amino acids, 0.1 mM 2-mercaptoethanol, 2 mM GlutaMAX™, and 50 U/mL penicillin-streptomycin
(all from Gibco®, Thermo Fisher Scientific, Grand Island, NY, USA). The embryoid body (EB) formation
was enhanced using overnight treatment with 5 µM blebbistatin (Sigma-Aldrich, St. Louis, MO, USA)
at +37 ◦C. Thereafter, the spontaneous RPE differentiation was induced by reducing the KO-SR to 15%.
The EBs differentiation was for 56 to 70 days. During this period, medium was replenished thrice a
week. After this period, pigmented areas were manually separated from EBs with a scalpel, dissociated
with TrypLE™ Select Enzyme, and acquired single-cell suspension filtered through a 100 µm BD Falcon
cell strainer (BD Biosciences, San Jose, CA, USA), and replated onto well plates coated with human
Collagen IV(COLIV, 5 µg/cm2, Sigma-Aldrich) to expand cell numbers and purify the cell population.
To expand and purify the culture further, this replating was repeated after 33 to 70 days.
4.5. Cultivation of hiPSC-RPEs for the Experiments
After the expansion of cells, the hiPSC-RPEs were dissociated with
Trypsin–ethylenediaminetetraacetic acid (EDTA), filtered through a strainer and counted to
be plated for the experiments on polyethylene terephthalate (PET) hanging cell culture inserts
with a 1.0 µm pore size (Merck Millipore Corporate, Billerica, MA, USA) which were coated on
10 µg/cm2 COL IV (Sigma-Aldrich St. Louis, MO, USA) and 0.75 µg/cm2 Laminin 521 (LN-521;
Biolamina, Sundbyberg, Sweden). Plated cells were grown in No-glucose DMEM medium with 2
mM GlutaMAX™, and 50 U/mL penicillin-streptomycin (all from Gibco, Thermo Fisher Scientific,
Grand Island, NY, USA) and 10% heat-inactivated FBS. This base was supplemented with d-glucose
or d-mannitol (both from Sigma-Aldrich) or +/− added human insulin (Gibco®, Thermo Fisher
Scientific). The high glucose (HG) medium contained 25 mM of glucose, normal glucose (NG) medium
contained 5 mM of glucose, isotonically balanced normal glucose medium (NGM) contained 5 mM
of glucose and 19.5 mM mannitol. To mimic the amount of insulin after the meal/fasting to the HG
medium, the amount of added insulin was higher (IU/mL equivalent to 6.94 ng/mL), whereas in the
NG or NGM medium, the amount of added insulin was lower (25 IU/mL, equivalent to 0.87 ng/mL).
Immediately after plating on PET inserts, the cells were grown in six different media with different
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glucose concentrations and with or without added insulin (HG−, HG+, NGM−, NGM+, NG−, NG+)
for 41 +/− 5 days, and the median was 35 days. The entire culture period from the EB culture until the
end of experiment was from 161 to 286 days, median was 188 days.
4.6. Experimental Treatments
The cellular stress was induced using 24 h treatment with 10 ng tumor necrosis factor α (TNFα,
Peprotech, London, U.K.), and a 1 h treatment with 300 mM hydrogen peroxide (H2O2, Sigma-Aldrich)
followed with a 23-h chase. The treatments for the autophagy function assessments were 24-h
treatments were starvation, which was done by omitting the FBS from the culture medium [48] or
by adding 20µM Resveratrol (Sigma-Aldrich) or 2 mM AICAR (5-aminoimidazole-4-carboxyamide
ribonucleoside, Toronto Research Chemical, North York, ON, Canada).
4.7. Indirect Immunofluorescence Staining
The same cultures that were subjected to the permeability test were used for indirect
immunofluorescent staining. Samples were first washed in 1× PBS, fixed with 4% paraformaldehyde for
10 min at room temperature (RT), and followed with four 1× PBS washes and permeabilized with 0.1%
TritonX-100 in 1× PBS for 10 min at RT. After that, the samples were washed repeatedly with PBS, and 3%
bovine serum albumin (BSA) in PBS was added to the samples for 1–1.5 h at RT or overnight at 4 ◦C to
block the nonspecific binding sites. The samples were then incubated with primary antibody against
tight junction specific with mouse-anti-ZO-1 (1:250 Invitrogen, Carlsbad, CA, USA) in 0.5% BSA-PBS
for 1 h at RT, and thereafter followed by four washes with 1× PBS. Samples were then incubated with
donkey-anti-mouse (Life Technologies, Paisley, UK) secondary antibody at a dilution of 1:1000 in 0.5%
BSA-PBS for 1 hour at RT. Finally, the samples were washed four times with 1× PBS mounted between
two cover glasses with Vectashield® mounting medium with 4′,5-diamidino-2-phenylindole (DAPI)
(Vector Laboratories Inc., Burlingame, CA, USA). The visualization and imaging of the stained samples
was carried out with an AxioScope A1 (Carl Zeiss, Jena, Germany) using a magnification of 40× and
resolution of 1200 × 1200.
4.8. Preparation of Transmission Electron Microscopy Samples
After 35 days of culture in different glucose concentrations, cells were fixed for 2 h at RT with
2% glutaraldehyde (Electron Microscopy Sciences, Hatfield, PA, USA) in a 0.1 M phosphate buffer,
and washed thereafter five times with 0.1 M phosphate buffer. The samples were postfixed with 1%
osmium tetroxide (Ladd Research, Williston, VT, USA) for 2 h at RT and thereafter washed thoroughly
with deionised water. The samples were then dehydrated through acetone series: 3 × 10 min 70%
acetone, 3 × 10 min 94% acetone, and 1 × 20 min and 1 × 30 min absolute acetone (J.T. Baker; Avantor
Performance Materials, B.V. Deventer, Arnhem, The Netherlands). Samples were impregnated with
a 1:1 mixture of absolute acetone and epoxy resin (Ladd Research, Williston, VT, USA) for 1.5 h at
RT. Thereafter, the excess acetone-epoxy resin solution was removed and replaced with pure epoxy
resin solution. Embedding with pure epoxy resin was done overnight at RT, and polymerization took
place for 48 h at 60 ◦C. Thin sections were stained with 1% uranyl acetate for 30 min and with 0.4%
lead citrate (Fluk, Steinheim, Switzerland) for 5 min. Samples were examined and imaged with a
JEM-2100F TEM (Jeol Ltd., Tokyo, Japan).
4.9. RNA Extraction and cDNA Synthesis
For the gene expression analyses, the total RNA was extracted from cell samples with a NucleoSpin
XS-kit (Macherey-Nagel, GmbH & Co., Düren, Germany) according to the manufacturer’s instructions.
The RNA concentration and its quality were assessed using a NanoDrop 1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA). RNA (40 ng) was reverse-transcribed to
complementary DNA using MultiScribe Reverse Transcriptase (Applied Biosystems, Foster City,
CA, USA) according to the manufacturer’s instructions in the presence of an RNase inhibitor.
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4.10. PCR Reaction
The RPE characteristics of hiPSC-RPEs was analyzed with RT-PCR using complementary DNA
as a template. The reaction was done using 5 µM primers specific for specific genes (Biomers.net
GmbH, Söflinger, Germany, Table 1), 5 U/µL Taq DNA Polymerase (Fermentas, Thermo Fisher Scientific
Inc., Leicestershire, U.K.) in PCR MasterCycler ep gradient (Eppendorf AG, Hamburg, Germany)
according the protocol: 95 ◦C 3 min, 95 ◦C 30 s, annealing 30 s, 72 ◦C 1 min, 72 ◦C 5 min, for 38 cycles.
Annealing temperatures and primer sequences are presented in Table 1. PCR products were resolved
in 2% agarose gels with a 50-bp DNA ladder (MassRulerTM DNA Ladder Mix, Fermentas, Thermo
Fisher Scientific Inc., Leicestershire, U.K.). The products were visualized with the Quantity One 4.5.2.
Basic program (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Table 1. Reverse-transcriptase–PCR primer sequences, product lengths (bp) and used annealing
temperatures (Tm). Primer sequences (5′ > 3′).
Gene Forward Reverse bp Tm
GAPDH GTTCGACAGTCAGCCGCATC GGAATTTGCCATGGGTGGA 229 55
OCT 3/4 CGTGAAGCTGGAGAAGGAGAAGCTG AAGGGCCGCAGCTTACACATGTTC 245 55
PAX6 AACAGACACAGCCCTCACAAACA CGGGAACTTGAACTGGAACTGAC 274 60
BEST GAATTTGCAGGTGTCCCTGT ATCAGGAGGACGAGGAGGAT 214 60
RPE65 TCC CCA ATA CAA CTG CCA CT CAC CACC ACA CTC AGA ACT A 316 52
Tyrosinase TGC CAA CGA TCC TAT CTT CC GAC ACA GCA AGC TCA CAA GC 316 52
4.11. Quantitative RT-PCR
The effects of different glucose concentrations was assessed by analyzing the expression of
glucokinase (GCK, Hs01564555_m1) which was done similarly as previously described in Kiamehr
et al. [49]. The effects of different glucose concentrations or glucose concentrations together with
cellular stress using TNFα and H2O2 was analyzed with qRT-PCR with TaqMan® gene expression
assays (Applied Biosystems, Inc., Foster City, CA, USA) using FAM labels. The expression of
collagen 4A1 (COL4A1, Hs00266237_m1), fibronectin 1 (FN1, Hs00365052_m1), and laminin A1 (LAMA1,
Hs00300550_m1) genes were analyzed and compared against the glyceraldehyde 3-phosphate dehydrogenase
(GAPDH; Hs99999905_m1), which was used as an endogenous control. Samples and template-less
controls of COL1A4, FN1, and LAMA1 were run in triplicate using the 7300 Real-Time PCR system
(Applied Biosystems, Inc. Inc., Foster City, CA, USA) with the following program: 2 min at 50 ◦C,
10 min at 95 ◦C; 40 cycles of 15 s at 95 ◦C, and finally 1 min at 60 ◦C. Results of COL1A4, FN1,
and LAMA1 were analyzed using 7300 System SDS Software 2.4 (Applied Biosystems, Inc. Inc., Foster
City, CA, USA). The relative quantification of each gene was calculated using Ct values and the 2−∆∆Ct
method [50] using GAPDH as a calibrator.
4.12. Trans-Epithelial Electrical Resistance
The barrier properties of the samples cultured in different glucose concentrations were evaluated
using trans-epithelial electrical resistance (TEER) analysis once a week during the four-week period
after plating hiPSC-RPEs on the PET insert. TEER values (Ω·cm2) were calculated by multiplying
the result by the surface area of the insert. TEER values were obtained from three to five individual
experiments with all hiPSC-RPE lines with two to three parallel samples, and two technical replicates.
4.13. Permeability Tests
After the five-week culture period, the cell culture inserts were cut from the holder and clamped
to a P2307 slider (Physiologic Instruments, San Diego, CA, USA) and placed into the Ussing Chamber
device (EM-CSYS-8, Physiologic Instruments) with P2300 EasyMount Diffusion Chambers with the
aperture of 0.03 cm2 to measure the barrier properties. Assessments were done similarly as in
Skottman et al. [51], except that the assessments were carried out in culture media containing the same
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concentration of glucose in which the sample was differentiated. Briefly, 1 mg/mL of 4 kDa fluorescein
isothiocyanate–dextran (FD4, Sigma-Aldrich) was used as the test molecule, and placed on the donor
side. Blank samples were taken prior to the test from both donor and acceptor media. The pH in the
chambers was kept constant with carbon dioxide gas (5% CO2, 10% O2, 85% N2). Once an hour for
4 hours, two parallel 100 µL samples were taken from the acceptor side of the chamber and 200 µL of
fresh medium on was added to balance the removed volume. The spectrophotometric assessment was
done with Wallac Victor2 1420 multilabel counter spectrophotometer (Turku, Finland). The cumulative
permeability value was calculated from the average value of the two parallel spectrophotometer
measurement values from which the value of pure medium (i.e., blank) was subtracted. This value was
then divided by the total volume of the acceptor side. The dilution effect of the added fresh medium
after every hour was taken into account in this step. Finally, this volume-adjusted value was divided
by the spectrophotometer value of the exposure medium and multiplied by 100%.
4.14. Enzyme-Linked Immunosorbent Assay
After the five-week culture period of hiPSC-RPEs on the 0.3 cm2 PET insert in different glucose
concentrations, the concentration of secreted PEDF was determined 24 h after the medium change with
a PEDF Enzyme-Linked Immunosorbent Assay (ELISA, BioVendor, Brno, Czech Republic) according
to the manufacturer’s instructions.
4.15. Western Blotting
For the Western blotting, the five-week cultured cell samples were washed once with PBS
(Lonza Group Ltd., Walkersville, MD, USA) and lysed in M-PER lysis buffer (Thermo Scientific,
Waltham, MA, USA) according to the manufacturer’s instructions. A total of 25–30 µg of whole cell
extracts were run in 15 % sodium dodecyl sulphate PAGE (SDS–PAGE) gels, wet-blotted to nitrocellulose
membranes (Amersham, Pittsburgh, PA, USA), and the unspecific binding sites on membranes blocked
using 3% skimmed milk powder in 0.3 % Tween-20/PBS at RT for 1.5 h. The labelling times and
primary antibodies against autophagy specific proteins p62/SQSTM1 and LC3, as well as housekeeping
protein α-tubulin, are presented in Table 2. After primary antibody incubations, the membranes were
washed three times for 5 min with the same buffer the antibodies were diluted with. The secondary
antibodies and dilution factors are presented in Table 2. After staining, similar to the previous washes,
the membranes were washed three times for 5 min with the same buffer the antibodies were diluted
with. Protein–antibody complexes were detected with an enhanced chemiluminescent assay for
horseradish peroxidase (Millipore, Billerica, MA, USA).
Table 2. The antibodies and dilution buffers used for Western blotting.
Protein
Primary Antibody Staining Secondary Antibody Staining
Buffer Used for
Dilution and WashingAntibody Cat, Producer,Dilution Antibody
Producer, Dilution,
Time











0.5% BSA in 0.3%
Tween-20/PBS









Scientific, 1:10,000, 2 h
5% BSA in 0.1%
Tween-20/TBS
(tris-buffered saline)
overnight at 4 ◦C










1% milk powder in
0.05 % Tween-20/PBS
for 1hrou at RT
4.16. Zymography
Medium from the apical and basal compartments was collected 24 hours after the medium change.
Zymography was conducted as previously described [52]. In brief, the medium from the apical and
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basal compartments was collected and 10 L conditioned media was mixed with 20 L nonreducing
zymogram sample buffer and loaded into the 0.1% gelatin-containing SDS-PAGE gel (10% Ready
Gel; BioRad, München, Germany). After electrophoresis, gels were incubated with renaturation
and development buffer (both BioRad). Afterward, gels were stained with Coomassie blue (BioRad)
and destained with a destaining solution (BioRad). Digital images of the gels were obtained with
a Chemibis chemoluminescence system (Biostep, Jena, Germany). For quantification, the inverted
gelatinase bands were analyzed with one-dimensional gel analysis software (TotalLab TL100; TotalLab
Ltd., Newcastle, U.K.). The molecular weight and band volume (density) was assessed. When the
effects of different glucose and insulin concentrations were compared, the 100 kDa molecular marker
(MW) was used as the calibrator. When the effects of cytokine or oxidative stress were evaluated, the b
band of the untreated control of the respective MMP was set as 1 (arbitrary unit).
4.17. Statistical Analyses
The statistical significance of numerical data were analyzed using PASW Statistics, version 18,
with a two tailed Mann–Whitney U test. The number of replicates is indicated in the figure legends.
4.18. Ethical Issues
The study was approved by the ethical committee of Pirkanmaa Hospital District (R12123) and
written consent was obtained from all fibroblast donors. All the patients were over 18 years old.
5. Conclusions
The type 2 diabetic hiPSC-RPE cells exhibited RPE type gene expression and PEDF secretion.
Diabetic hiPSC-RPEs had a higher cumulative permeability than normal controls. Added insulin
increased the epithelial layer tightness in normal glucose concentrations, and the effect was clearer
in type 2 diabetic hiPSC-RPEs than in healthy control hiPSC-RPEs. The preliminary functionality
assessment under oxidative stress and autophagy and cytokine stimuli showed that the autophagic
stimulation had no effect on LC3-II but induced accumulation of p62/SQSTM1, and cytokine stimuli
decreased pro-MMP2 expression and increased pro-MMP9 expression in type 2 diabetic hiPSC-RPEs.
These results suggest that the used cell model has potential to study diabetes-derived cellular
stress alterations.
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